Document ID: chunk:federal_register_of_legislation:F2025L00212:clause:1_2550
Version: federal_register_of_legislation:F2025L00212
Segment Type: clause
Provision Reference: sch 1 cl 2550
Character Range: 1191538–1192702

2550                                      HEXYLRESORCINOL                                            A         Permitted for use only in medicated throat lozenges.
                                                                                                               The medicine of must not contain more than 2.5 mg of hexylresorcinol per lozenge.
                                                                                                               The maximum recommended daily dose of the medicine must not provide more than 30mg of hexylresorcinol.
                                                                                                               The medicine label must specify that the medicine is only to be used for 7 days (or less).
                                                                                                               The following warning statement must be included on the medicine label:
                                                                                                               - (PREGNT) 'Not recommended for use by pregnant and lactating women' (or words to that effect).